Skip to main content

This website contains promotional content and is intended for Healthcare Professionals based in the United Kingdom only. Some content may only be relevant to HCPs practising in Great Britain (England, Scotland and Wales) according to product availability. This website is optimised for desktop use, and some features may perform differently on mobile devices.

Adverse event reporting can be found at the bottom of the page.

Dupixent my way logo

Disclaimer: These resources should be downloaded and given to your patient(s) who have been prescribed DUPIXENT®.  Your patient(s) must not be directed towards this website as it is intended for healthcare professionals only. However, once prescribed, patients will be given access to the patient website www.dupixentmyway.co.uk through patient materials.

The resources contained within this section are updated regularly by Sanofi. Before you use any of the resources, or provide any resources to your patients please re-visit this page to ensure that you are using the most up-to-date version(s).

Patient Support

What is DUPIXENT Patient Support?

Dupixent MyWay is a dedicated website for your patients that have been prescribed Dupixent. 

The DUPIXENT Patient Support Programme, DUPIXENT MyWay, is designed for patients with the goal of encouraging your patients to make effective use of DUPIXENT.

It provides information to help support and educate Patients on their DUPIXENT treatment to increase levels of self-confidence and ability to manage both their condition and treatment regimen.

Dispense and delivery

Nurse-led injection training

Patient support programme

Home Delivery and Patient Support Services

Please also give your patient or their carer the Home Delivery and Patient Support Service leaflet which can be found in the Patient Support Resource section below, designed to let your patients know what to expect from the service

Patient Support Resources

Find resources and support for your patients on DUPIXENT. This Includes information about treatment, how to inject guides, travelling with DUPIXENT information and support resources.

Welcome to Dupixent Patient Handbook

In this guide, patients can learn what inflammation is, how DUPIXENT works, and get answers to commonly asked questions.

Download
Patient Abbreviated Leaflet - Severe Asthma

This guide provides information about how DUPIXENT aims to treat Severe Asthma and where to get more information and support.

Download
Patient Abbreviated Leaflet - COPD

This guide provides information about how DUPIXENT aims to treat Chronic obstructive pulmonary disease (COPD) and where to get more information and support.

Download
Home Delivery and Patient Support Service leaflet 

Leaflet designed to let your patients know what to expect from the service

Download
Injecting DUPIXENT® Your ‘how-to’ guide 

In this guide, patients can find instructions and tips for successfully managing injections at home.

Download
DUPIXENT Comic Booklet - Severe Asthma

The DUPIXENT comic has been designed to help children explore what their condition is and what to expect with DUPIXENT.

Download

Patient Website

Find resources and support for your patients on DUPIXENT. This Includes information about treatment, how to inject guides, travelling with DUPIXENT information and support resources.

All patients starting treatment on Homecare services will receive a patient pack with all of the appropriate resources to their home.

Order patient materials either via your local representative or Contact Medical Information on +44 (0) 800 035 2525 (Monday Friday, 8:30-17:30, excluding public holidays)

Learn more about Dupixent (dupilumab) for your patients

MAT-XU-2402679 (v3.0) Date of Preparation: February 2026  

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to the Sanofi drug safety department on Tel: +44 (0) 800 0902 314. Alternatively, send via email to UK-drugsafety@sanofi.com